Long-term results of rituximab treatment for membranous nephropathy after allogeneic hematopoietic SCT: a case report.
D
D
Mattei
R
R
Sorasio
A
A
Guarnieri
F
F
Marazzi
M
M
Formica
M
M
Fortunato
N
N
Mordini
D
D
Rapezzi
A
A
Gallamini
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D001228:Aspergillosis; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000209:etiology; D006086:Graft vs Host Disease; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab